BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar V, Benjamin J, Shasthry V, Subramanya Bharathy KG, Sinha PK, Kumar G, Pamecha V. Sarcopenia in Cirrhosis: Fallout on Liver Transplantation. J Clin Exp Hepatol 2020;10:467-76. [PMID: 33029056 DOI: 10.1016/j.jceh.2019.12.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Falari SS, Mohapatra N, Patil NS, Pattnaik B, Varshney M, Choudhury A, Sarin SK, Pamecha V. Low Incidence of Alcohol Relapse following Living Donor Liver Transplantation.. [DOI: 10.21203/rs.3.rs-1983402/v1] [Reference Citation Analysis]
2 Motsiuk VM, Pentiuk NO. Radiological psoas muscle parameters as a reliable tool for detection of sarcopenia and prediction of short-term survival in liver cirrhosis. Rep of Morph 2022;28:5-13. [DOI: 10.31393/morphology-journal-2022-28(3)-01] [Reference Citation Analysis]
3 De A, Kumari S, Kaur A, Singh A, Kalra N, Singh V. Hand-grip strength as a screening tool for sarcopenia in males with decompensated cirrhosis. Indian J Gastroenterol. [DOI: 10.1007/s12664-022-01255-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kulkarni AV, Premkumar M, Reddy DN, Rao PN. The challenges of ascites management: An Indian perspective. Clin Liver Dis (Hoboken) 2022;19:234-8. [PMID: 35795622 DOI: 10.1002/cld.1209] [Reference Citation Analysis]
5 Khan S, Benjamin J, Maiwall R, Tripathi H, Kapoor PB, Shasthry V, Saluja V, Agrawal P, Thapar S, Kumar G. Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis. J Clin Transl Res 2022;8:200-8. [PMID: 35813898] [Reference Citation Analysis]
6 Nguyen M, Mukaneza Y, Tremblay M, Huard G, Tang A, Rose CF, Bémeur C. Renal dysfunction independently predicts muscle mass loss in patients following liver transplantation. CanLivJ. [DOI: 10.3138/canlivj-2021-0042] [Reference Citation Analysis]
7 Premkumar M, Anand AC. Overview of Complications in Cirrhosis. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.04.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Iacob S, Mina V, Mandea M, Iacob R, Vadan R, Boar V, Ionescu G, Buzescu D, Gheorghe C, Gheorghe L. Assessment of Sarcopenia Related Quality of Life Using SarQoL® Questionnaire in Patients With Liver Cirrhosis. Front Nutr 2022;9:774044. [DOI: 10.3389/fnut.2022.774044] [Reference Citation Analysis]
9 Raghu VK, Sico R, Rudolph JA, Mazariegos GV, Squires J, Squires JE. Sarcopenia prevalence in pediatric intestinal transplant recipients: Implications on post‐transplant outcomes. Pediatric Transplantation. [DOI: 10.1111/petr.14256] [Reference Citation Analysis]
10 Ferreira AP, Machado MV. Impact of pretransplant frailty and sarcopenia on the post-transplant prognosis of patients with liver cirrhosis: a systematic review. Eur J Gastroenterol Hepatol 2021;33:e883-97. [PMID: 35048655 DOI: 10.1097/MEG.0000000000002291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Anand A, Saraya A. Assessment of Sarcopenia in Chronic Liver Disease: Indian Perspective. Clin Liver Dis (Hoboken) 2021;18:164-7. [PMID: 34691405 DOI: 10.1002/cld.1142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lan G, Yu C, Huang Y. The adverse impact, assessment and management of sarcopenia in liver transplantation candidates and recipients. Hepatobiliary Surg Nutr 2021;10:575-8. [PMID: 34430549 DOI: 10.21037/hbsn-21-145] [Reference Citation Analysis]
13 Singh S, Taneja S, Tandon P, Bansal A, Gorsi U, Roy A, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.07.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
14 Pamecha V, Sinha PK, Rajendran V, Patil NS, Mohapatra N, Rastogi A, Patidar Y, Choudhury A. Living donor liver transplantation for hepatocellular carcinoma in Indian patients- Is the scenario different? Indian J Gastroenterol 2021;40:295-302. [PMID: 34019241 DOI: 10.1007/s12664-020-01138-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Son SW, Song DS, Chang UI, Yang JM. Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:349. [PMID: 33923561 DOI: 10.3390/life11040349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Singh SA, Madan K, Rastogi R, Agarwal AR, Gupta S, Thakur R. Relevance of Population-Based Cutoffs to Define Sarcopenia in Clinical Studies. J Clin Exp Hepatol 2021;11:276-7. [PMID: 33746455 DOI: 10.1016/j.jceh.2020.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]